ArticleJournal of arrhythmia2025
National Trends in Arrhythmias and Heart Failure Related Mortality in the United States From 1999 to 2023: A CDC Wonder Analysis.
Article in Journal of arrhythmia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Trends and disparities in deaths involving atherosclerotic cardiovascular disease and stroke-related conditions among U.S. adults, 1999-2025.Frontiers in cardiovascular medicine · 2026Article
- National Trends in Arrhythmias and Heart Failure Related Mortality in the United States From 1999 to 2023: A CDC Wonder Analysis.Journal of arrhythmia · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Arrhythmias are an important contributing cause of death in patients with heart failure (HF). Despite advancements in cardiovascular care, the burden of arrhythmia-related mortality in HF patients remains a significant public health concern. This study aims to evaluate national trends in arrhythmia-related mortality in HF patients from 1999 to 2023. Methods: Mortality data for patients with arrhythmias (ICD-10 codes: I44.0-I49.9) and HF (ICD-10 codes: I11.0, I13.0, I13.2, I50.0, I50.1, and I50.9) was obtained from the CDC WONDER Database. Age-adjusted mortality rates (AAMRs) were calculated per 100 000 populations. Joinpoint regression was used to assess the annual percentage changes in AAMR. Results: Between 1999 and 2023, arrhythmias and HF were responsible for 1 428 953 deaths in the United States. A notable increase in arrhythmia-related mortality among HF patients during 2018-2021 (APC = 5.77%) was observed. Sex-based disparities revealed higher mortality (AAMR: 37.61) in males. Racial and ethnic disparities were evident, with non-Hispanic American Indians showing the highest AAPC (2.95). State-level variations indicated that Oregon reported the highest AAMR (47.106), while Nevada reported the lowest (16.74). Geographic analysis showed higher mortality rates in non-metropolitan areas. Conclusion: The observed reduction in arrhythmia-related mortality in HF patients over the last two decades suggests promising advancements in public health strategies and cardiovascular care. However, the persistent disparities across geographic, demographic, and healthcare access lines underscore the need for deeper investigation into the underlying causes of these trends.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.